SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001072613-14-000309
Filing Date
2014-08-04
Accepted
2014-08-04 17:19:19
Documents
1
Group Members
CLARUS VENTURES I LLCCLARUS VENTURES I MANAGEMENT L.P.DENNIS HENNERKURT WHEELERMICHAEL STEINMETZNICHOLAS GALAKATOSNICHOLAS SIMONROBERT LIPTAK

Document Format Files

Seq Description Document Type Size
1 VBI VACCINES INC. clarus-vbi13d_17677.htm SC 13D 289384
  Complete submission text file 0001072613-14-000309.txt   291390
Mailing Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142
Business Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142 6178303031
VBI VACCINES INC. (Subject) CIK: 0000704159 (see all company filings)

IRS No.: 930589534 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-41542 | Film No.: 141013881
SIC: 6211 Security Brokers, Dealers & Flotation Companies

Mailing Address 101 MAIN STREET SUITE 1210 CAMBRIDGE MA 02142
Business Address 101 MAIN STREET SUITE 1210 CAMBRIDGE MA 02142 617-949-2200
Clarus Lifesciences I, L.P. (Filed by) CIK: 0001431445 (see all company filings)

IRS No.: 203855540 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D